v3.26.1
Condensed consolidated statements of operations and comprehensive loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
Research and development $ 101,061 $ 19,522 $ 171,934 $ 29,651
General and administrative 20,312 11,129 34,099 21,457
Total operating expenses 121,373 30,651 206,033 51,108
Loss from operations (121,373) (30,651) (206,033) (51,108)
Other Nonoperating Income (Expense) [Abstract]        
Interest income 9,994 2,126 15,710 3,801
Other income (expense), net 72 (422) 151 377
Total other income 10,066 1,704 15,861 4,178
Net loss (111,307) (28,947) (190,172) (46,930)
Other comprehensive loss        
Unrealized loss (1,262) (26) (2,023) (32)
Comprehensive loss $ (112,569) $ (28,973) $ (192,195) $ (46,962)
Net loss per share attributable to common stockholders - basic $ (1.09) $ (28,947) $ (3.72) $ (46,930)
Net loss per share attributable to common stockholders - diluted $ (1.09) $ (28,947) $ (3.72) $ (46,930)
Weighted-average common stock outstanding - basic 102,226,608 1 51,124,108 1
Weighted-average common stock outstanding - diluted 102,226,608 1 51,124,108 1